SNX

171.65

-0.2%↓

PII

67.75

-1.53%↓

SNX

171.65

-0.2%↓

PII

67.75

-1.53%↓

SNX

171.65

-0.2%↓

PII

67.75

-1.53%↓

SNX

171.65

-0.2%↓

PII

67.75

-1.53%↓

SNX

171.65

-0.2%↓

PII

67.75

-1.53%↓

Search

Nu Skin Enterprises Inc

Gesloten

9.93 0.71

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

9.81

Max

10.23

Belangrijke statistieken

By Trading Economics

Inkomsten

-4M

17M

Verkoop

-22M

364M

K/W

Sectorgemiddelde

4.466

16.516

EPS

0.34

Dividendrendement

2.5

Winstmarge

4.689

Werknemers

3,100

EBITDA

-11M

32M

Dividenden

By Dow Jones

Dividendrendement

Sectorgemiddelde

2.50%

2.74%

Volgende Winsten

12 feb 2026

Volgende dividenddatum

4 mrt 2026

Volgende Ex Dividend datum

23 feb 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-53M

477M

Vorige openingsprijs

9.22

Vorige sluitingsprijs

9.93

Technische score

By Trading Central

Vertrouwen

Bearish Evidence

Nu Skin Enterprises Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

10 feb 2026, 23:26 UTC

Belangrijke Marktbewegers

Moderna Stock Slips After FDA Refuses Flu Vaccine Review

10 feb 2026, 22:31 UTC

Winsten

Correction to America Movil 4Q Profit Article

10 feb 2026, 22:22 UTC

Winsten

America Movil 4Q Profit Jumps on Lower Financial Costs

10 feb 2026, 23:51 UTC

Marktinformatie
Winsten

Commonwealth Bank's Margin Management Gives It a Platform -- Market Talk

10 feb 2026, 23:42 UTC

Marktinformatie

Gold Rises Amid Fed Rate-Cut Prospects -- Market Talk

10 feb 2026, 23:40 UTC

Marktinformatie
Winsten

Commonwealth Bank Bear Says 1H Result Looks Strong -- Market Talk

10 feb 2026, 23:21 UTC

Marktinformatie

Ford Says EV Shift Was Driven by Demand Changes -- Market Talk

10 feb 2026, 23:21 UTC

Marktinformatie

Global Equities Roundup: Market Talk

10 feb 2026, 22:17 UTC

Marktinformatie

Australia's One Nation Now Commands Working Class Vote -- Market Talk

10 feb 2026, 22:15 UTC

Winsten

Humana Earnings Will Shed More Light on Medicare Prospects -- Barrons.com

10 feb 2026, 22:10 UTC

Winsten

Intact Financial 4Q Book Value Per Share Was C$107.35 >IFC.T

10 feb 2026, 22:10 UTC

Winsten

Intact Financial Raises Qtr Dividend to C$1.47 >IFC.T

10 feb 2026, 22:09 UTC

Winsten

Intact Financial 4Q Combined Ratio Was 85.9% >IFC.T

10 feb 2026, 22:09 UTC

Winsten

Intact Financial 4Q Adj EPS C$5.50 >IFC.T

10 feb 2026, 22:01 UTC

Winsten

Intact Financial 4Q EPS C$5.24 >IFC.T

10 feb 2026, 21:54 UTC

Winsten

James Hardie Industries Sees FY26 Total Adjusted EBITDA $1.232B to $1.263B >JHX

10 feb 2026, 21:53 UTC

Winsten

Robinhood Stock Tumbles as Crypto-Related Revenue Falls Short of Expectations -- Barrons.com

10 feb 2026, 21:51 UTC

Winsten

James Hardie Industries Sees FY26 Free Cash Flow at Least $200M

10 feb 2026, 21:51 UTC

Winsten

Gilead Earnings Surprise. Why The Stock Is Tumbling Anyway. -- Barrons.com

10 feb 2026, 21:51 UTC

Winsten

James Hardie Industries: Focused on the Achievement of $125 M Target >JHX

10 feb 2026, 21:51 UTC

Winsten

James Hardie Industries: Integration and Cost Synergies Ahead of Schedule >JHX

10 feb 2026, 21:51 UTC

Winsten
Acquisities, Fusies, Overnames

Evolution Net Debt A$362 Million at Dec. 31 Vs A$1.29 Billion Year Earlier

10 feb 2026, 21:50 UTC

Winsten
Acquisities, Fusies, Overnames

Evolution: Gearing 6% at Dec. 31, From 23% a Year Earlier

10 feb 2026, 21:50 UTC

Winsten

James Hardie Industries 3Q EPS 12c >JHX

10 feb 2026, 21:50 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

10 feb 2026, 21:50 UTC

Winsten

James Hardie Industries 3Q Adj EPS 24c >JHX

10 feb 2026, 21:49 UTC

Winsten

James Hardie Industries 3Q Sales $1.24B >JHX

10 feb 2026, 21:49 UTC

Winsten
Acquisities, Fusies, Overnames

Evolution 1H Operating Mine Cash Flow a Record A$1.73 Billion

10 feb 2026, 21:48 UTC

Winsten
Acquisities, Fusies, Overnames

Evolution 1H Ebitda A$1.56 Billion, Up 59% On-Year

10 feb 2026, 21:47 UTC

Winsten
Acquisities, Fusies, Overnames

Evolution 1H Revenue A$2.79 Billion, Up 37% On-Year

Peer Vergelijking

Prijswijziging

Nu Skin Enterprises Inc Prognose

Beoordelingsconsensus

By TipRanks

0 ratings

0

Buy

0

Hold

0

Sell

Technische score

By Trading Central

5.78 / 6.16Steun & Weerstand

Korte Termijn

Bearish Evidence

Gemiddeld Termijn

Strong Bearish Evidence

Lange Termijn

Neutral Evidence

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Nu Skin Enterprises Inc

Nu Skin Enterprises, Inc., together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products. The company also provides wellness products, such as LifePak nutritional supplements, ageLOC TR90 weight management system, and Beauty Focus Collagen+. In addition, it is involved in the research and product development of skin care products and nutritional supplements. The company sells its products under the Nu Skin, Pharmanex, and ageLOC brands through retail stores, website, digital platforms, and independent direct sellers and marketers, as well as a service center. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.
help-icon Live chat